Clinical Applications and Validation of Probiotics: Exploring Therapeutic and Preventive Potential Across Diverse Medical Conditions
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 717
Special Issue Editors
Interests: microbiome; probiotics; preventive medicine; artificial intelligence in medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Probiotics have gained increasing attention for their role in and restoration of a healthy microbiota, which is crucial for overall health.
This Special Issue of Microorganisms focuses on the use of probiotics in various clinical settings, with particular attention being paid to their role in the prevention and treatment of diverse diseases, including neuropsychiatric, autoimmune, metabolic, and gastrointestinal disorders.
The selection of probiotic strains is critical, as specific bacterial characteristics and properties must be tailored to address distinct clinical needs.
This Special Issue aims to showcase recent advances in the clinical validation of probiotic formulations and explore how novel probiotic blends can be integrated into therapeutic and preventive practices. By highlighting clinical studies and real-world applications, this issue seeks to provide valuable insights into the potential of probiotics as an adjunct or alternative approach in managing a wide array of medical conditions.
Dr. Francesco Broccolo
Dr. Marcello Romeo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- probiotics
- microbiota
- clinical validation
- therapeutic applications
- preventive therapy
- novel probiotic blends
- medical conditions
- specific strains
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
